Feeds › Lobbying
Lobbying
Who pays Washington lobbyists, how much, and on which issues.
About this data
- What it is
- Companies and trade groups that pay for lobbying must report it to Congress every quarter: who they hired, how much they spent, and which issues were lobbied.
- Who files it
- The lobbying firm, or the company itself when it uses its own staff, under the Lobbying Disclosure Act.
- How current
- Quarterly reports are due 20 days after each quarter ends, so they arrive in waves. We collect them daily.
- Worth knowing
- Amounts are rounded by the filer and cover the whole quarter. We match clients to listed companies automatically, so a few may be missed or misattributed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Lobbying filings per day, last 30 days
All filings Of listed companies
Quarterly reports are due 20 days after each quarter ends, so filings come in waves.
Latest lobbying filings
Showing: ticker CVS
| Posted | Client | Lobbying firm | Report | AmountWhen a company hires a lobbying firm, the firm reports the income it received. When the company lobbies with its own staff, it reports its expenses instead. | Issues | Filing |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | CVS CVS Health Corporation | CVS Health (and Subsidiaries) | 2026 third quarter | $2.0M | PHA, TAX, MMM, INS | LDA ↗ |
| Oct 20, 2026 | CVS CVS Health Corporation | Thegroup DC, LLC | 2026 third quarter | $50.0K | HCR, PHA | LDA ↗ |
| Oct 20, 2026 | CVS CVS Health Corporation | Michael Best Strategies LLC | 2026 third quarter | $110.0K | HCR, PHA, MMM, INS | LDA ↗ |
| Oct 20, 2026 | CVS CVS Health Corporation | Capitol Hill Consulting Group | 2026 third quarter | $60.0K | MMM, HCR | LDA ↗ |
| Oct 20, 2026 | CVS CVS Health Corporation | ALB Solutions | 2026 third quarter | $70.0K | HCR | LDA ↗ |
| Oct 20, 2026 | CVS CVS Health Corporation | Alston & Bird LLP | 2026 third quarter | $30.0K | HCR | LDA ↗ |
| Oct 19, 2026 | CVS CVS Health Corporation | Bockorny Group, Inc. | 2026 third quarter | $100.0K | PHA | LDA ↗ |
| Oct 19, 2026 | CVS CVS Health Corporation | Continental Strategy, LLC | 2026 third quarter | $105.0K | HCR | LDA ↗ |
| Oct 8, 2026 | CVS CVS Health Corporation | Kountoupes Denham Carr & Reid, LLC | 2026 third quarter | $60.0K | PHA, MMM | LDA ↗ |
| Jul 21, 2026 | CVS CVS Health Corporation | Capitol Hill Consulting Group | 2026 second quarter | $60.0K | MMM, HCR | LDA ↗ |
| Jul 20, 2026 | CVS CVS Health Corporation | CVS Health (and Subsidiaries) | 2026 second quarter | $3.6M | PHA, TAX, LBR, CSP | LDA ↗ |
| Jul 20, 2026 | CVS CVS Health Corporation | Thegroup DC, LLC | 2026 second quarter | $50.0K | HCR, PHA | LDA ↗ |
| Jul 20, 2026 | CVS CVS Health Corporation | Bockorny Group, Inc. | 2026 second quarter | $100.0K | PHA | LDA ↗ |
| Jul 20, 2026 | CVS CVS Health Corporation | Alston & Bird LLP | 2026 second quarter | $20.0K | HCR | LDA ↗ |
| Jul 20, 2026 | CVS CVS Health Corporation | Michael Best Strategies LLC | 2026 second quarter | $110.0K | PHA, MMM, INS, HCR | LDA ↗ |
| Jul 19, 2026 | CVS CVS Health Corporation | Continental Strategy, LLC | 2026 second quarter | $105.0K | HCR | LDA ↗ |
| Jul 16, 2026 | CVS CVS Health Corporation | ALB Solutions | 2026 second quarter | $70.0K | HCR | LDA ↗ |
| Jul 15, 2026 | CVS CVS Health Corporation | Kountoupes Denham Carr & Reid, LLC | 2026 second quarter | $60.0K | PHA, MMM | LDA ↗ |
| Apr 21, 2026 | CVS CVS Health Corporation | Capitol Hill Consulting Group | 2026 first quarter | $60.0K | MMM, HCR | LDA ↗ |
| Apr 21, 2026 | CVS CVS Health Corporation | Thegroup DC, LLC | 2026 first quarter | $50.0K | HCR, PHA | LDA ↗ |
| Apr 20, 2026 | CVS CVS Health Corporation | CVS Health (and Subsidiaries) | 2026 first quarter | $3.3M | CSP, ADV, PHA, TAX | LDA ↗ |
| Apr 20, 2026 | CVS CVS Health Corporation | Alston & Bird LLP | 2026 first quarter | $30.0K | HCR | LDA ↗ |
| Apr 20, 2026 | CVS CVS Health Corporation | Michael Best Strategies LLC | 2026 first quarter | $40.0K | HCR, PHA, MMM, INS | LDA ↗ |
| Apr 20, 2026 | CVS CVS Health Corporation | Bockorny Group, Inc. | 2026 first quarter | $100.0K | PHA | LDA ↗ |
| Apr 17, 2026 | CVS CVS Health Corporation | Continental Strategy, LLC | 2026 first quarter | $105.0K | HCR | LDA ↗ |
| Apr 15, 2026 | CVS CVS Health Corporation | Kountoupes Denham Carr & Reid, LLC | 2026 first quarter | $60.0K | PHA, MMM | LDA ↗ |
| Apr 15, 2026 | CVS CVS Health Corporation | ALB Solutions | 2026 first quarter | $70.0K | HCR | LDA ↗ |
| Apr 15, 2026 | CVS CVS Health Corporation | Keefe Strategies LLC FKA Keefe Singiser Partners | 2026 first quarter | — | LDA ↗ | |
| Apr 9, 2026 | CVS CVS Health Corporation | Klein/Johnson Group | 2026 first quarter | — | LDA ↗ | |
| Mar 30, 2026 | CVS CVS Health Corporation | Michael Best Strategies LLC | 2026 first quarter | — | HCR, PHA, MMM, INS | LDA ↗ |
| Jan 21, 2026 | CVS CVS Health Corporation | Thegroup DC, LLC | 2025 fourth quarter | $50.0K | HCR, PHA | LDA ↗ |
| Jan 20, 2026 | CVS CVS Health Corporation | CVS Health (and Subsidiaries) | 2025 fourth quarter | $2.3M | PHA, TAX, MMM, INS | LDA ↗ |
| Jan 20, 2026 | CVS CVS Health Corporation | Klein/Johnson Group | 2025 fourth quarter | $50.0K | LBR, PHA, CSP | LDA ↗ |
| Jan 20, 2026 | CVS CVS Health Corporation | Capitol Hill Consulting Group | 2025 fourth quarter | $60.0K | MMM | LDA ↗ |
| Jan 20, 2026 | CVS CVS Health Corporation | Alston & Bird LLP | 2025 fourth quarter | $30.0K | HCR | LDA ↗ |
| Jan 20, 2026 | CVS CVS Health Corporation | Bockorny Group, Inc. | 2025 fourth quarter | $105.0K | PHA | LDA ↗ |
| Jan 19, 2026 | CVS CVS Health Corporation | Continental Strategy, LLC | 2025 fourth quarter | $105.0K | HCR | LDA ↗ |
| Jan 18, 2026 | CVS CVS Health Corporation | ALB Solutions | 2025 fourth quarter | $50.0K | HCR | LDA ↗ |
| Jan 15, 2026 | CVS CVS Health Corporation | Keefe Strategies LLC FKA Keefe Singiser Partners | 2019 first quarter | — | PHA, HCR | LDA ↗ |
| Jan 15, 2026 | CVS CVS Health Corporation | Kountoupes Denham Carr & Reid, LLC | 2025 fourth quarter | $60.0K | PHA, MMM | LDA ↗ |
| Jan 15, 2026 | CVS CVS Health Corporation | Keefe Strategies LLC FKA Keefe Singiser Partners | 2025 fourth quarter | $30.0K | HCR, PHA | LDA ↗ |
| Oct 20, 2025 | CVS CVS Health Corporation | Thegroup DC, LLC | 2025 third quarter | $50.0K | HCR, PHA | LDA ↗ |
| Oct 20, 2025 | CVS CVS Health Corporation | CVS Health (and Subsidiaries) | 2025 third quarter | $2.1M | PHA, TAX, MMM, INS | LDA ↗ |
| Oct 20, 2025 | CVS CVS Health Corporation | Continental Strategy, LLC | 2025 third quarter | $105.0K | HCR | LDA ↗ |
| Oct 20, 2025 | CVS CVS Health Corporation | Klein/Johnson Group | 2025 third quarter | $50.0K | LBR, PHA, CSP | LDA ↗ |
| Oct 20, 2025 | CVS CVS Health Corporation | ALB Solutions | 2025 third quarter | $50.0K | HCR | LDA ↗ |
| Oct 20, 2025 | CVS CVS Health Corporation | Alston & Bird LLP | 2025 third quarter | $30.0K | HCR | LDA ↗ |
| Oct 20, 2025 | CVS CVS Health Corporation | Bockorny Group, Inc. | 2025 third quarter | $105.0K | PHA | LDA ↗ |
| Oct 19, 2025 | CVS CVS Health Corporation | Capitol Hill Consulting Group | 2025 third quarter | $60.0K | MMM | LDA ↗ |
| Oct 19, 2025 | CVS CVS Health Corporation | Capitol Hill Consulting Group | 2025 second quarter | $60.0K | MMM | LDA ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:08 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances